SB/Bristol Avandia Co-Promotion Unveiled Following Cmte. Recommendation
Executive Summary
The Avandia co-promotion agreement between SmithKline Beecham and Bristol-Myers Squibb in the U.S. draws on Bristol's market knowledge in the diabetes field and the complex synergy of Bristol's Glucophage and the new SB agent.
You may also be interested in...
CV Therapeutics Ranexa Pre-Launch Steps Will Ramp Up After Cmte. Review
CV Therapeutics expects to begin hiring Ranexa sales reps following the chronic angina therapy's review by FDA's Cardiovascular & Renal Drugs Advisory Committee in September, the company said July 17
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011